• Mashup Score: 0

    A phase III study using cediranib and olaparib to treat recurrent platinum-sensitive ovarian cancer did not meet its primary endpoint of progression-free survival but did produce comparable activity to standard of care platinum-based chemotherapy treatment.

    Tweet Tweets with this article
    • A phase 3 study using cediranib & olaparib to treat recurrent platinum-sensitive ovarian cancer did not meet its primary end point of PFS but did produce comparable activity to standard of care platinum-based chemotherapy. @DanaFarber #ASCO20 #gyncsm https://t.co/n43In39xen

  • Mashup Score: 0

    An overlapping case of Sjögren’s syndrome can lower the likelihood of achieving remission or low disease activity among patients with rheumatoid arthritis, according to data published in Arthritis Research & Therapy.“A growing number of cross-sectional studies have shown that RA-SS patients tend to have more severe arthritis and visceral involvement than those without

    Tweet Tweets with this article
    • #Sjogrens syndrome plus #rheumatoidarthritis lower the likelihood of achieving #remission or low disease activity https://t.co/1s824Agvk8